Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

NovaSecta Forms Alliance with Sundia MediTech and HD BioSciences

publication date: Feb 18, 2008

NovaSecta, an R&D advisory company located in England that specializes in advising smaller and mid-sized biopharmas, announced an alliance with a China CRO consortium – the coalition formed by Sundia MediTech and HD BioSciences in 2007. NovaSecta seeks to provide its mid-sized clients with R&D alternatives. These can include managing its R&D efforts or establishing strategic outsourcing partnerships. NovaSecta has also formed a multi-company R&D program that comprises eight mid-sized biopharmas in seven European countries. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here